Category: Pharmaceutical company
Quick infos Headquarters: Massachusetts, United States Trade prices Volume: Market Cap: 864.19M Prev closed: Open: 15.61 High: 15.89 Low: 15.03 52 week low: 15.03 52 week high: 73.02 Dividends: No Dividends Next ER: August 9, 2023
About the Company Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPRâCas9 gene editing technology. The company went public on 2 Feb 2016.
Earnings History Date EPS / Forecast Revenue / Forecast August 9, 2023 May 5, 2023 -0.79 / -0.799.9M / 3.29MBeat! February 22, 2023 -0.88 / -0.796.5M / 3.66MBeat! November 2, 2022 -0.81 / -0.852942K / 4.39MBeat! August 3, 2022 -0.78 / -0.80836.4M / 4.29MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Jun 14, 2023 11.09 11.54 11.91
10.82
2.5M -3.31% Jun 13, 2023 11.47 9.6 11.68
9.6
4.5M 15.51% Jun 12, 2023 9.93 9.7 10.06
9.35
4.3M 2.69% Jun 9, 2023 9.67 9.96 10.13
9.38
1.6M 0.73% Jun 8, 2023 9.6 10.51 10.53
9.34
2.4M -8.75% Jun 7, 2023 10.52 10.38 10.69
10
1.9M 2.63% Jun 6, 2023 10.25 9.45 10.57
9.36
2.0M 8.58% Jun 5, 2023 9.44 9.6 9.63
9.31
1.9M -2.38% Jun 2, 2023 9.67 9.69 9.93
9.42
1.3M 1.26% Jun 1, 2023 9.55 9.17 9.62
9
1.2M 4.03% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Why Editas Medicine Stock Is Sliding Today finance.yahoo.com Jun 16, 2023 11:59 am
Why Editas Medicine Stock Charged Higher in January finance.yahoo.com Jun 16, 2023 11:33 am
Earnings Preview: Editas Medicine (EDIT) Q1 Earnings Expected to Decline finance.yahoo.com Jun 16, 2023 10:02 am
Editas Medicine (EDIT) Crossed Above the 50-Day Moving Average: What That Means for Investors finance.yahoo.com Jun 16, 2023 9:30 am
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings finance.yahoo.com Jun 16, 2023 9:00 am Editas shares jump 9% on positive news from sickle-cell study finance.yahoo.com Jun 16, 2023 8:00 am
Proceed With Caution When Considering These 5 Ultra-Popular Stocks finance.yahoo.com Jun 16, 2023 5:25 am Editas Medicine shares slip after proposing $125M stock offering seekingalpha.com Jun 15, 2023 4:24 am
Editas Medicine Announces Offering of Common Stock finance.yahoo.com Jun 14, 2023 4:05 pm Editas upgraded to overweight at Raymond James on sickle cell candidate seekingalpha.com Jun 13, 2023 2:20 am Editas posts initial data for gene editing candidate for blood disorders seekingalpha.com Jun 9, 2023 10:41 pm
Editas Medicine Reports Inducement Grant to New Chief Financial Officer finance.yahoo.com May 18, 2023 4:30 pm
Industry Analysts Just Upgraded Their Editas Medicine, Inc. (NASDAQ:EDIT) Revenue Forecasts By 14% finance.yahoo.com May 10, 2023 6:02 am
Editas Medicine First Quarter 2023 Earnings: Beats Expectations finance.yahoo.com May 6, 2023 8:14 am
Editas Medicine Announces Publication in Nature Biotechnology of Comprehensive SLEEK Gene Editing Technology Data finance.yahoo.com May 1, 2023 4:01 pm
Is Editas Medicine (NASDAQ:EDIT) In A Good Position To Invest In Growth? finance.yahoo.com Mar 27, 2023 6:19 am
Editas (EDIT) Posts Upbeat Initial Data From SCD & TDT Studies finance.yahoo.com Jun 12, 2023 10:00 am
Why Is Emergent Biosolutions (EBS) Down 21.4% Since Last Earnings Report? finance.yahoo.com Jun 8, 2023 11:30 am Editas Medicine appoints Erick Lucera as CFO, Michelle Robertson steps down seekingalpha.com May 17, 2023 4:58 am Editas Medicine GAAP EPS of -$0.71 beats by $0.08 seekingalpha.com May 5, 2023 7:05 pm This company doesn't provide a dividend.
Key Persons Talk about Editas below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 38 HOLD 46 SELL 15
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet